Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy plus QL1706 for relapsed or chemo-resistant gestational trophoblastic neoplasia
ChiCTR2500105758Phase 2Not yet recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Jul 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of QL1706 in trophoblastic tumour, sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoints: Overall survival, Progression-free survival and 1 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
QL1706
03
Conditions
trophoblastic tumour
Beyond the preview
Go deeper on ChiCTR2500105758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105758.